Global Sterile Injectable Drugs Market to 2023 by Molecule Type, Drug Class, Application and Geography - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 1, 2018--The “Global Sterile Injectable Drugs Market - Segmented by Molecule Type, Drug Class, Application and Geography - Growth, Trends, and Forecast (2018 - 2023)” report has been added to ResearchAndMarkets.com’s offering.
The sterile injectable drugs market is expected to register a growth rate of about 10.5% over the forecast period, 2018 to 2023.
The increasing number of biologics, antibody-drug conjugates, and monoclonal antibodies in development, as well as clinical trials, has led primarily led to the growth of the sterile injectable drugs. The development and manufacture of the sterile injectable are slow and often the industry deals with the shortage of these products primarily due to the complexity and capital-intensive nature of these products.
As per the regional analysis, the recent changes in the US Food and Drug Administration (FDA) regulations on manufacturing sites, along with large presence of multinational medical devices companies, diseases management and awareness in the society are expected to have positive effects over the forecast period, which helps North America to retain its dominance in this market.
In the past one era of healthcare, biologics are increasingly becoming the driving forces of the pharmaceutical industry and prefilled syringes have gained increased acceptance as delivery systems for injectable drugs for the treatment of chronic diseases. Prefilled syringes are mainly sterilized via autoclaving or by ionizing radiation.
Market DriversRising R&D Focus on Development of Biotechnology-Engineered Anti-Cancer Drugs Rapid Growth in the Usage of in Pre-filled Syringes for Biologic Products Increased out-sourcing Activities across Value Chain Expected to Boost Supply of Injectable Products
Market RestraintsHigh Expenses Associated with Inventory Management Stringent Regulatory Requirement for High-End Machinery
Key Topics Covered:
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Market Dynamics
7. Market Segmentation
8. Competitive Landscape
9. Key PlayersAmgen Baxter Gilead Sciences Inc. GlaxoSmithKline plc Johnson & Johnson Merck & Co. Inc Novartis AG Novo Nordisk A/S Pfizer Inc Sanofi
For more information about this report visit https://www.researchandmarkets.com/research/r7b55w/global_sterile?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181001005646/en/
Laura Wood, Senior Manager
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Infusions and Injectables
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/01/2018 10:35 AM/DISC: 10/01/2018 10:35 AM